Home/Hedge Fund Intelligence/Bright Minds Biosciences Inc.
Nasdaq: DRUGStockForm 13F30 Jun 2026

Hedge funds that hold Bright Minds Biosciences Inc. New Nasdaq: DRUG

New · CUSIP 10919W405 · who reports it, how much, and how much it matters to them

24 of the 720 hedge fund managers we track reported shares of Bright Minds Biosciences Inc. (Nasdaq: DRUG) on Form 13F for 30 June 2026. Between them they reported USD 243m. The largest position belongs to Cormorant Asset Management, at USD 63m. The manager with the most riding on it is Acuta Capital Partners, where it is 4.5% of the reported book.

Managers reporting it24of 720 we track
Value they reportUSD 243mshares only, 30 Jun 2026
Funds they run209with a file on PPLI.com
Largest positionUSD 63mCormorant Asset Management
Typical weight0.0%median share of a manager's book
Heaviest weight4.5%Acuta Capital Partners

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

24 managers, USD 243m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Bright Minds Biosciences Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Cormorant Asset Management1 fund on PPLI.comUSD 63m3.2%
2Braidwell12 funds on PPLI.comUSD 34m1.3%
3Balyasny Asset Management25 funds on PPLI.comUSD 24m0.0%
4Adage Capital Management1 fund on PPLI.comUSD 24m0.0%
5POINT72 Asset Management17 funds on PPLI.comUSD 23m0.0%
6Ra Capital Management1 fund on PPLI.comUSD 19m0.2%
7Great Point Partners2 funds on PPLI.comUSD 7.7m1.5%
8Orbimed Advisors1 fund on PPLI.comUSD 6.5m0.1%
9Acuta Capital Partners2 funds on PPLI.comUSD 6.5m4.5%
10Sio Capital Management4 funds on PPLI.comUSD 5.2m0.9%
11Millennium Management6 funds on PPLI.comUSD 4.7m0.0%
12Citadel Advisors32 funds on PPLI.comUSD 4.7m0.0%
13Schonfeld Strategic Advisors30 funds on PPLI.comUSD 4.7m0.0%
14Walleye Capital8 funds on PPLI.comUSD 4.6m0.0%
15Artia Global Partners1 fund on PPLI.comUSD 2.7m0.5%
16Superstring Capital Management1 fund on PPLI.comUSD 2.1m1.4%
17Boothbay Fund Management2 funds on PPLI.comUSD 2m0.0%
18Aquatic Capital Management3 funds on PPLI.comUSD 1.5m0.1%
19Platinum Investment Management11 funds on PPLI.comUSD 1.3m0.3%
20Exome Asset Management2 funds on PPLI.comUSD 710,0000.4%
21Two Sigma Investments35 funds on PPLI.comUSD 674,0000.0%
22Tudor Investment Corporation10 funds on PPLI.comUSD 582,0000.0%
23Engineers Gate Manager1 fund on PPLI.comUSD 380,0000.0%
24The Quarry1 fund on PPLI.comUSD 1,8950.0%
Next: where it matters most
Where it matters most

For Acuta Capital Partners it is 4.5% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Acuta Capital PartnersUSD 6.5m4.5%
2Cormorant Asset ManagementUSD 63m3.2%
3Great Point PartnersUSD 7.7m1.5%
4Superstring Capital ManagementUSD 2.1m1.4%
5BraidwellUSD 34m1.3%
6Sio Capital ManagementUSD 5.2m0.9%
7Artia Global PartnersUSD 2.7m0.5%
8Exome Asset ManagementUSD 710,0000.4%
9Platinum Investment ManagementUSD 1.3m0.3%
10Ra Capital ManagementUSD 19m0.2%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Bright Minds Biosciences Inc.

What is the ticker symbol of Bright Minds Biosciences Inc.?

Bright Minds Biosciences Inc. trades under the symbol DRUG on the Nasdaq. Its CUSIP, the code used on Form 13F, is 10919W405.

Which hedge funds own Bright Minds Biosciences Inc. (Nasdaq: DRUG)?

24 of the 720 hedge fund managers PPLI.com tracks reported Bright Minds Biosciences Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Cormorant Asset Management (USD 63m), Braidwell (USD 34m), Balyasny Asset Management (USD 24m), Adage Capital Management (USD 24m) and POINT72 Asset Management (USD 23m).

How many hedge funds hold Bright Minds Biosciences Inc.?

24 managers in our coverage reported it, and between them they run 209 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Bright Minds Biosciences Inc.?

Acuta Capital Partners, where the position was 4.5% of the reported 13F book at 30 June 2026.

Does this show who is short Bright Minds Biosciences Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Bright Minds Biosciences Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.